RxDoctor Payments DataLook up a doctor →

Xhance: payments to doctors

Payments that named Xhance as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$9.4M
Providers
17,120
Transactions
113,431
Average per transaction
$83

The per-transaction average — $83 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 17,120 providers the average total is $551, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Optinose US, Inc.$9,372,67399.3%
Paratek Pharmaceuticals, Inc.$64,7720.7%
Kaleo, Inc.$1,2530.0%
← All drugs & devices